CurrentRheuma
Get Weekly

Topic · page 8 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 281–320 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Osteoporos Int

    Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial

    Randomized controlled trial

  2. Osteoporos Int

    Pre-fracture functional status and 30-day recovery predict 5-year survival in patients with hip fracture: findings from a prospective real-world study

    Cohort study

  3. Osteoporos Int

    Association of β-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis

    Meta-analysis

  4. Osteoporos Int

    Osteoporosis medication use over time in the United States and Canada

    Cross-sectional study

  5. Arthritis Res Ther

    A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers

    Cohort study

  6. JAMA Netw Open

    Mediterranean Diet, Physical Activity, and Bone Health in Older Adults: A Secondary Analysis of a Randomized Clinical Trial

    Secondary analysis

  7. Osteoporos Int

    Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

    Guideline or statement

  8. Osteoporos Int

    Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures

    Diagnostic or prognostic study

  9. Osteoporos Int

    A cost-consequence analysis of a community-based rehabilitation programme following hip fracture (Fracture in the Elderly Multidisciplinary Rehabilitation—FEMuR III)

    Randomized controlled trial

  10. Osteoporos Int

    Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies

    Cohort study

  11. Osteoporos Int

    Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study

    Mechanistic study

  12. Osteoporos Int

    Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case–control study with a mean 7-year follow-up

    Cohort study

  13. Osteoporos Int

    Prevalence and risk factors for osteoporosis in type 1 diabetes—results from an observational study

    Cross-sectional study

  14. Osteoporos Int

    Notable lacking of bone mineral density measurement in cushing syndrome: a nationwide study based on the US insurance claim database

    Cohort study

  15. Osteoporos Int

    Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial

    Randomized controlled trial

  16. Osteoporos Int

    Ensemble-learning approach improves fracture prediction using genomic and phenotypic data

    Diagnostic or prognostic study

  17. Osteoporos Int

    Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006–2022)

    Cohort study

  18. Osteoporos Int

    PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis

    Meta-analysis

  19. Osteoporos Int

    Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis patients

    Cohort study

  20. Osteoporos Int

    Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness—the osteolaus study

    Cohort study

  21. JAMA Netw Open

    Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools

    Cross-sectional study

  22. Osteoporos Int

    Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE

    Secondary analysis

  23. Ann Rheum Dis

    Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures

    Cohort study

  24. Osteoporos Int

    The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population

    Cohort study

  25. Joint Bone Spine

    Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO

    Guideline or statement

  26. Osteoporos Int

    Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM

    Guideline or statement

  27. JAMA

    Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force

    Meta-analysis

  28. JAMA

    Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

    Guideline or statement

  29. Osteoporos Int

    The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs)

    Cohort study

  30. Osteoporos Int

    Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system

    Cohort study

  31. Osteoporos Int

    Identifying proximal humerus fractures: an algorithmic approach using registers and radiological visit data

    Diagnostic or prognostic study

  32. Osteoporos Int

    Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women

    Cohort study

  33. Osteoporos Int

    Association between vertebral fractures and brain volume: insights from a community cohort study

    Cross-sectional study

  34. Osteoporos Int

    Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis

    Cross-sectional study

  35. Osteoporos Int

    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment

    Cohort study

  36. Osteoporos Int

    Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018

    Cross-sectional study

  37. Lupus Sci Med

    Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus

    Cohort study

  38. Osteoporos Int

    Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study

    Case-control study

  39. N Engl J Med

    Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age

    Randomized controlled trial

  40. Osteoporos Int

    A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification

    Diagnostic or prognostic study

All 659 Briefs in ExploreShowing Briefs 281–320 of 659, newest first